Omnicell (OMCL) Other Operating Expenses (2010 - 2022)

Omnicell (OMCL) reported Other Operating Expenses of -$3.5 million for Q1 2022, down 75.0% year-over-year from -$14.0 million in Q1 2021, and down 75.0% quarter-over-quarter from -$2.0 million in Q1 2021.

Omnicell (OMCL) Other Operating Expenses (2010 - 2022) Analysis & Trends

Omnicell (OMCL) has 4 years of Other Operating Expenses data on file, last reported at -$3.5 million in Q1 2022.

  • Other Operating Expenses for Q1 2022 came in at -$3.5 million, down 75.0% year-over-year; the trailing twelve-month figure through Dec 2022 was -$3.5 million (down 75.0% YoY), and the FY2015 annual result was -$3.4 million, changed N/A from the prior year.
  • Other Operating Expenses fell to -$3.5 million in Q1 2022 per OMCL's latest filing, from -$2.0 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at -$2.0 million in Q1 2021 and troughed at -$3.5 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn
10 Teladoc Health 1.31 Bn 562.23 Mn 562.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 -3.50 Mn
Mar 31, 2021 -2.00 Mn
Jun 30, 2015 -3.44 Mn
Sep 30, 2010 -43,000.00